BioStem Technologies (BioStem Technologies) Change In Receivables : $-0.05 Mil (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Change In Receivables?

BioStem Technologies's change in receivables for the quarter that ended in Sep. 2023 was $0.00 Mil. It means BioStem Technologies's Accounts Receivable stayed the same from Mar. 2023 to Sep. 2023 .

BioStem Technologies's change in receivables for the fiscal year that ended in Dec. 2022 was $0.26 Mil. It means BioStem Technologies's Accounts Receivable declined by $0.26 Mil from Dec. 2021 to Dec. 2022 .

BioStem Technologies's Accounts Receivable for the quarter that ended in Sep. 2023 was $2.91 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioStem Technologies's Days Sales Outstanding for the three months ended in Sep. 2023 was 73.86.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioStem Technologies's liquidation value for the three months ended in Sep. 2023 was $-6.80 Mil.

BioStem Technologies Change In Receivables Historical Data

The historical data trend for BioStem Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Change In Receivables Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-0.17

0.10

0.07

-0.29

0.26

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Change In Receivables	Get a 7-Day Free Trial															-0.50	-	-	-0.05	-

BioStem Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

BioStem Technologies (OTCPK:BSEM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioStem Technologies's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2.913	/	3.599	*	91
=	73.86

2. In Ben Graham's calculation of liquidation value, BioStem Technologies's accounts receivable are only considered to be worth 75% of book value:

BioStem Technologies's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.11	-	9.34	+	0.75 * 2.913	+	0.5 * 0.495
=	-6.80

BioStem Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.